Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir
To access this article, please choose from the options below
PII: S1386-6532(09)00477-6
doi:10.1016/j.jcv.2009.09.029
© 2009 Elsevier B.V. All rights reserved.
